Hasan, Shahnaz
Iqbal, Amir
Ibrahim, Abeer Ramadan
Diab, Reham H.
Iqbal, Zaheen A.
Hasan, Tabinda
Anwer, Shahnawaz
Alghadir, Ahmad H.
Article History
Received: 5 October 2025
Accepted: 13 March 2026
First Online: 22 March 2026
Declarations
:
: The study was approved by the Ethics Sub-Committee, King Saud University, Riyadh, Saudi Arabia (approval ID: RRC-2021-17). The trial was prospectively registered with the ClinicalTrials.gov Protocol Registration and Results System (PRS) under the identifier: NCT05577403, dated: 12/07/2021 (initial release), and the record was subsequently updated on 14/09/2025 ( ). The study adhered to the ethical standards of the World Medical Association Declaration of Helsinki (2010). All participants provided written informed consent prior to study enrolment.
: Not applicable.
: The authors declare no competing interests.